Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The cytokine network in asthma and chronic obstructive pulmonary disease
Peter J. Barnes
Peter J. Barnes
View: Text | PDF
Review Series

The cytokine network in asthma and chronic obstructive pulmonary disease

  • Text
  • PDF
Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are very common inflammatory diseases of the airways. They both cause airway narrowing and are increasing in incidence throughout the world, imposing enormous burdens on health care. Cytokines play a key role in orchestrating the chronic inflammation and structural changes of the respiratory tract in both asthma and COPD and have become important targets for the development of new therapeutic strategies in these diseases.

Authors

Peter J. Barnes

×

Figure 2

Cytokines involved in COPD.

Options: View larger image (or click on image) Download as PowerPoint
Cytokines involved in COPD.
Inhaled irritants, such as cigarette smoke, ...
Inhaled irritants, such as cigarette smoke, activate epithelial cells and macrophages to release multiple cytokines, including growth factors such as TGF-β and FGFs, which stimulate fibroblast proliferation, resulting in fibrosis in the small airways. These cells also secrete the proinflammatory cytokines TNF-α, IL-1β, and IL-6, all of which amplify inflammation, and several chemokines that attract circulating cells into the lungs. CCL2 acts via CCR2 to attract monocytes (which differentiate into macrophages in the lungs); CXCL1 and CXCL8 act via CXCR2 to attract neutrophils and monocytes; and CXCL9, CXCL10, and CXCL11 act via CXCR3 to attract Th1 cells and Tc1 cells, both of which release IFN-γ, which in turn stimulates the release of more of these CXCR3-binding chemokines. Mucus hypersecretion is stimulated by EGF and TGF-α. CTGF, connective tissue growth factor. Adapted with permission from Nature Publishing Group (1).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts